Wobenzym: Clinical Trials

6 trials of Wobenzym, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Completed 1
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Wobenzym: new trials by email Literature Review of Wobenzym trials Research Report on Wobenzym

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis
Wobenzym®, Placebo - Osteoarthritis
Not applicableCompletedMucos Pharma GmbH & Co. KG402021-04-302024-11-22
The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
Wobenzym plus, PL 1 - Inflammation, Death, Sudden, Cardiac
Phase 1CompletedTechnical University of Munich1602013-08-012015-06-30
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise
Wobenzym® plus, Placebo - Muscle Injury, Muscle Soreness
Phase 4CompletedMucos Pharma GmbH & Co. KG692013-02-012015-08-28
The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults
Diclofenac, Wobenzym, Placebo - Wobenzym, Osteoarthritis
Phase 2CompletedAtrium Innovations1502000-11-012014-03-17
Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
Phlogenzym, Placebo - Thrombophlebitis Leg
Phase 3CompletedMucos Pharma GmbH & Co. KG1001996-09-012018-03-19
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
Wobenzym - HIV Infections
Phase 1CompletedMucos Pharma GmbH and Co2005-06-24

Conditions studied

Inflammation (2)  ·  Osteoarthritis (2)  ·  AIDS-Related Complex (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Blood Coagulation Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Death (1)  ·  Death, Sudden (1)  ·  Death, Sudden, Cardiac (1)  ·  HIV Infections (1)  ·  Heart Diseases (1)  ·  Motor Activity (1)  ·  Myalgia (1)  ·  Pathologic Processes (1)  ·  Respiratory Tract Infections (1)

Sponsors

Mucos Pharma GmbH & Co. KG (3)  ·  Atrium Innovations (1)  ·  Mucos Pharma GmbH and Co (1)  ·  Technical University of Munich (1)

Countries

Germany (3)  ·  Belgium (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Didier Urbin-Choffray (1)  ·  Gerhard Stauder, Dr (1)  ·  Helmut Pabst, Dr. med (1)  ·  Jean-Emile Dubuc (1)  ·  Johannes Scherr, Dr. med. (1)  ·  Karl Brabants (1)  ·  Marcel Baumueller, MD (1)  ·  Siddhartha Lieten (1)  ·  Valerie Badot (1)

Results publications

PMID 24559067, PMID 26093876, PMID 29370708, PMID 40803821